Invesco Faces Earnings With Analysts Split and an Activist on the Register

Invesco reports third-quarter results on October 27, carrying a stock that has dropped 9% over the past month to $28.06 while a cluster of Wall Street target-price revisions pulls in opposite directions.

Options positioning tells the more striking story. Call buying has overwhelmed put demand to an unusual degree, with the put/call ratio at 0.21, nearly two standard deviations below its 20-day average of 0.28. That is close to the most call-heavy reading of the past year, and it sits in contrast to the price weakness: the shares are down on the day and down sharply over the month, yet options traders are not reaching for downside protection. The borrow market adds little to the short case. Availability is effectively uncapped, with roughly 437 million shares still available to lend against a short position of under 16 million. Short interest is 3.6% of the free float, up about 26% over the past month in absolute share terms but still a modest level in context. The cost to borrow has doubled in a month to 0.51%, though that remains low in absolute terms.

Analyst sentiment around the print is genuinely mixed, and the dispersion in targets is wide. Morgan Stanley's Michael Cyprys raised his target to $32 on October 22, maintaining an Equal-Weight rating, which puts him below the current consensus mean of $34.71. UBS moved the most aggressively, lifting its target to $41 and upgrading to Buy earlier this month. BMO Capital and RBC both raised targets to $36 while keeping Outperform ratings. Pulling the other way, TD Cowen trimmed to $38 and Evercore ISI cut to $34 from $37, both retaining existing ratings. The stock at $28.06 sits well below even the most cautious targets, implying the Street broadly sees upside, but the range from $32 to $41 reflects real disagreement about how far Invesco can recover. The company ranks in the 81st percentile for EPS surprise and the 90th for analyst recommendation divergence, both factors that amplify the uncertainty around any single print.

The activist register adds another layer of complexity. Nelson Peltz holds a Schedule 13D position in Invesco, most recently disclosed at 4.62% of shares outstanding. A 13D filing signals active engagement, not passive ownership, and Peltz's stake makes any management commentary on strategy and capital allocation particularly watched. The disclosure caveat applies: positions are as-last-disclosed around the 5% threshold, and the filing dates to May 2025, so the current stake size is unconfirmed. Wikipedia traffic for Invesco has spiked, with a retail-attention z-score of 2.55 against its own 90-day history, a sign that the name is drawing more interest than usual in the run-up to the release.

Insider activity over the past 90 days has run net negative, with $7.2 million more sold than bought on an open-market basis. The CFO sold roughly $1 million in early September. Most of the other activity involves compensation-related grants and tax-withholding transactions rather than discretionary trades, so the signal is weaker than the headline net figure implies. Peers moved in different directions on Friday, with ARES and CG each gaining more than 5% on the day while Invesco fell 2.5%, pointing to stock-specific pressure rather than a sector-wide move.

The October 27 print will test whether Invesco's AUM trends and fee revenue can justify a re-rating toward the analyst consensus, or whether the gap between the $28 share price and even the most cautious $32 target reflects a structural discount the quarterly numbers alone cannot close.